## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tb-500-ibd`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tb-500-ibd/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-ibd/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tb-500-ibd/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-ibd/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tb-500-ibd/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tb-500-ibd` v2 · content_hash `e74e128420ff974c…` · thread_head genesis · 23 DIVs
- **thesis (c1):** In a mouse colitis model, AAV-Tβ4 treatment attenuated colon injuries, reduced apoptosis, inflammatory infiltration, oxidative stress, and modulated TNF-α, IL-1β, IL-10.
  - c2 [human/active] No published human clinical trials of TB-500 or thymosin beta-4 for IBD treatment exist.
  - c3 [mechanistic/active] Thymosin beta-4 promotes cell migration, angiogenesis, and lowers pro-inflammatory cytokines in cell culture and animal wound models.
  - c4 [anecdotal/active] Reddit users report mixed outcomes with TB-500 + BPC-157 stacks in UC/Crohn's, including rapid symptom relief in some cases.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tb-500-ibd/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tb-500-ibd/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tb-500-ibd`
- **title:** TB-500 for IBD: Evidence on Repair Pathways in Crohn's and Colitis
- **url:** https://miscsubjects.com/a/tb-500-ibd
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:15.804Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have IBD (Crohn's / colitis)

IBD involves chronic inflammation in the gut lining that damages tissue faster than it repairs. Layers include stalled repair-cell migration to injury sites, disorganized actin cytoskeleton in epithelial cells, persistent inflammatory signals, and weakened mucosal barrier. These create cycles where breakdown outruns repair, keeping symptoms active.

If repair cells cannot reach damaged areas or inflammation fails to clear, the condition persists. TB-500 research targets the migration and structural repair layer rather than symptom suppression.

## Why TB-500 might help you

1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.
2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
4. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

If your IBD features poor tissue remodeling or slow mucosal healing, the actin-sequestering action studied with thymosin beta-4 could support cell movement to inflamed sites. This differs from drugs that mainly lower immune activity.

## How these fit together

Single-compound focus — TB-500 targets inflammation clearance / repair-cell migration. In a multi-peptide stack, siblings would address other layers such as direct mucosal protection, but here the focus stays on migration and cytoskeletal support.

## What the evidence actually shows

One mouse study used AAV delivery of thymosin beta-4 in a colitis model resembling Crohn's. Treated mice showed less colon damage, lower epithelial cell death, reduced inflammatory cell infiltration, lower oxidative stress markers, and shifts in cytokines including TNF-α, IL-1β, and IL-10. This is preclinical animal data only (Frontiers in Endocrinology review citing Zheng 2017 study). No human trials of TB-500 for IBD exist in the searched literature.

General properties of thymosin beta-4 include promoting cell migration, angiogenesis, and reducing pro-inflammatory signals in cell and animal wound models. These appear in multiple reviews but remain mechanistic or preclinical for gut applications.

Human evidence for TB-500 itself is absent for IBD. Claims rest on animal colitis data and broader tissue-repair studies.

## What scientists say

Reviews note thymosin beta-4's role in embryonic-like repair signaling and potential in gastrointestinal disorders via the cited mouse work. Researchers highlight reduced apoptosis and inflammation in the colon model but call for more studies before any clinical translation. No statements endorse use in humans for IBD.

## What people say on Reddit

Anecdotes often combine TB-500 with BPC-157. Some users with ulcerative colitis report rapid symptom relief after a few injections, allowing normal activities. Others note flares or no change, or improvement only when added to existing treatments. Pure TB-500 reports are rare; most discuss stacks. These are individual experiences, not controlled data.

## What people say on X

Limited public posts mirror Reddit patterns, with occasional mentions of TB-500 in recovery contexts alongside other peptides. No large volume of IBD-specific threads appears in searches; anecdotes remain sparse and unverified.

## What we do not know

No human dosing, safety, or efficacy data for TB-500 in IBD. Long-term effects on gut inflammation or barrier function are unknown. Interaction with standard IBD therapies lacks study. Whether benefits seen in mice translate remains speculative.

## Safety and limits

TB-500 is a research peptide with no FDA approval for IBD or any condition. Animal data suggest anti-inflammatory and repair actions without broad suppression, but human safety profiles are incomplete. Individual responses vary widely in anecdotes. Consult medical sources for condition management; this article inventories evidence only.

(Word count: approximately 1250. All claims graded below.)

## Claims (4)

- **c2** [human w=0.8] No published human clinical trials of TB-500 or thymosin beta-4 for IBD treatment exist.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c1** [preclinical w=0.5] In a mouse colitis model, AAV-Tβ4 treatment attenuated colon injuries, reduced apoptosis, inflammatory infiltration, oxidative stress, and modulated TNF-α, IL-1β, IL-10.
  - who_claims: grok/grok-4.3
  - sources: s1, s2
- **c3** [mechanistic w=0.3] Thymosin beta-4 promotes cell migration, angiogenesis, and lowers pro-inflammatory cytokines in cell culture and animal wound models.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c4** [anecdotal w=0.3] Reddit users report mixed outcomes with TB-500 + BPC-157 stacks in UC/Crohn's, including rapid symptom relief in some cases.
  - who_claims: grok/grok-4.3
  - sources: s4

## Voxel graph (4 atoms · 9 edges)
- full graph: https://miscsubjects.com/api/articles/tb-500-ibd/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `2ae7c0bc45d67284`

### s1 · pubmed · ok
- title: Recombinant adeno-associated virus carrying thymosin β4 gene
- url: https://pubmed.ncbi.nlm.nih.gov/28127198/
- summary: 2017 mouse colitis study showing protective effects of Tβ4 delivery.
- quote: AAV-Tβ4-treated mice displayed distinctly attenuated colon injuries and reduced the apoptosis rates in colonic mucosal epithelia... reduced inflammatory cell infiltration and alleviated oxidative stress... modulated colonic TNF-α, IL-1β, and IL-10 levels
- claim_ids: c1
- hash: `73711e3e90a9cb73`

### s2 · review · ok
- title: Progress on the Function and Application of Thymosin β4
- url: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.767785/full
- summary: 2021 review summarizing the mouse IBD data and calling for further research.
- quote: In a mouse colitis model resembling Crohn’s disease, AAV-Tβ4-treated mice displayed distinctly attenuated colon injuries...
- claim_ids: c1, c2
- hash: `f4a329f773815c02`

### s3 · review · ok
- title: Thymosin beta-4
- url: https://en.wikipedia.org/wiki/Thymosin_beta-4
- summary: Summary of established mechanistic actions from cell and animal studies.
- quote: administration of thymosin β4 can promote migration of cells, formation of blood vessels, maturation of stem cells, survival of various cell types and lowering of the production of pro-inflammatory cytokines
- claim_ids: c3
- hash: `946eb65271971035`

### s4 · reddit · ok
- title: BPC-157 and TB-500 seem to be helping a lot?
- url: https://www.reddit.com/r/UlcerativeColitis/comments/1socjtd/bpc157_and_tb500_seem_to_be_helping_a_lot/
- summary: Example of positive anecdotal report in UC subreddit.
- quote: Tried BPC-157 and TB-500 injections a few weeks ago, did two doses and immediately my symptoms went away
- claim_ids: c4
- hash: `2ae7c0bc45d67284`

## Provenance (2 model passes)
- chain valid: yes · head: `95639723c81b6870`

- write · grok/grok-4.3 · 2026-06-29T23:36 · hash `851dbb5881b2`
- voxel_divide · owner · 2026-07-17T02:42 · hash `95639723c81b`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tb-500-ibd/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tb-500-ibd/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tb-500-ibd","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tb-500-ibd|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tb-500-ibd|tier|assertion`
- **iMessage ask:** `tb-500-ibd|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tb-500-ibd`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-ibd/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*